The Boston ScientificCorporation (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neurovascular intervention, electrophysiology, vascular surgery, endoscopy, oncology, urology and gynaecology. A corporation is a legal entity (distinct from a natural person) that often has similar rights in law to those of a Civil law systems may refer to corporations as moral persons; they may also go by the name AS (anonymous society) or something similar, depending on language (see below). ... New York Stock Exchange (June 2003) The New York Stock Exchange (NYSE) is the second largest stock exchange in the world. ... Manufacturing is the transformation of raw materials into finished goods for sale, or intermediate processes involving the production or finishing of semi-manufactures. ... Cardiology is the branch of medicine dealing with disorders of the heart and blood vessels. ... Electrophysiology is the science and branch of physiology that pertains to the flow of ions in biological tissues and, in particular, to the electrical recording techniques that enable the measurement of this flow and the potential changes related to them. ... Vascular surgery is the branch of surgery that occupies itself with surgical interventions of arteries and veins, as well as conservative therapies for disease of the peripheral vascular system. ... Endoscopy means looking inside and refers to looking inside the human body for medical reasons. ... Please refer to cancer for the biology of malignant disease, as well as a list of malignant diseases. ... Urology is the field of medicine that focuses on the urinary tracts of males and females, and of the male reproductive system. ... The shamefulness associated with the examination of female genitalia has long inhibited the science of gynaecology. ...
External links
Welcome to Boston Scientific
Yahoo! - Boston Scientific Corporation Company Profile
BSC believes that a reduction in barriers to trade with the corresponding effects of increasing efficiencies, reducing costs, and increasing quality of care is a key component of reducing overall health care costs.
BSC would like to take this opportunity to draw the Subcommittees attention to Japan as an example of a country in which we have traditionally had significant market access problems, and where a new regulatory initiative in the healthcare system may undermine the progress that has been made by our trade negotiators in recent years.
BSC urges the Members of this Subcommittee, as well as key officials in the Administration, to impress upon Japan the full measure of our commitment to see to it that market access is improved in real terms in the medical device sector.
BostonScientific Corp. yesterday recalled all of its Hemashield Vantage vascular grafts after disclosing that the devices could fray or tear during suturing and lead to complications.
BostonScientific said just 500 grafts that had not been implanted remained in the distribution pipeline yesterday.
BostonScientific said it is ''working with the US Food and Drug Administration" and also notifying officials in other countries.
Feeds |
Contact